Pharmacotherapy for benign prostatic hyperplasia — the potential for α1‐adrenoceptor subtype‐specific blockade
作者： Chapple
DOI: 10.1046/J.1464-410X.1998.0810S1034.X
关键词:
摘要:
sci-hub.se 参考文章(98)
Seiji Furuya, Yoshiaki Kumamoto, Eiji Yokoyama, Taiji Tsukamoto, Takashi Izumi, Yasushi Abiko, Alpha-Adrenergic Activity and Urethral Pressure in Prostatic Zone in Benign Prostatic Hypertrophy The Journal of Urology. ,vol. 128, pp. 836- 839 ,(1982) , 10.1016/S0022-5347(17)53216-4
Glenn J. Gormley, Elizabeth Stoner, Reginald C. Bruskewitz, Julianne Imperato-McGinley, Patrick C. Walsh, John D. McConnell, Gerald L. Andriole, Jack Geller, Bruce R. Bracken, Joyce S. Tenover, E. Darracott Vaughan, Frances Pappas, Alice Taylor, Bruce Binkowitz, Jennifer Ng, The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. The New England Journal of Medicine. ,vol. 327, pp. 1185- 1191 ,(1992) , 10.1056/NEJM199210223271701
David T Price, Debra A Schwinn, Jon W Lomasney, Lee F Allen, Marc G Caron, Robert J Lefkowitz, Identification, Quantification, and Localization of mRNA for Three Distinct Alpha1 Adrenergic Receptor Subtypes in Human Prostate The Journal of Urology. ,vol. 150, pp. 546- 551 ,(1993) , 10.1016/S0022-5347(17)35544-1
J.M. Buzelin, S. Roth, C. Geffriaud-Ricouard, M.C. Delàuche-Cavailier, and the ALGEBI Study Group, Efficacy and safety of sustained-release alfuzosin 5 mg in patients with benign prostatic hyperplasia. ALGEBI Study Group European Urology. ,vol. 31, pp. 190- 198 ,(1997) , 10.1159/000474449
C.S. Ramarao, J.M. Denker, D.M. Perez, R.J. Gaivin, R.P. Riek, R.M. Graham, Genomic organization and expression of the human alpha 1B-adrenergic receptor. Journal of Biological Chemistry. ,vol. 267, pp. 21936- 21945 ,(1992) , 10.1016/S0021-9258(19)36703-1
D A Schwinn, J W Lomasney, W Lorenz, P J Szklut, R T Fremeau, T L Yang-Feng, M G Caron, R J Lefkowitz, S Cotecchia, Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. Journal of Biological Chemistry. ,vol. 265, pp. 8183- 8189 ,(1990) , 10.1016/S0021-9258(19)39055-6
Shaul Perlberg, Marco Caine, Adrenergic response of bladder muscle in prostatic obstruction: Its relation to detrusor instability Urology. ,vol. 20, pp. 524- 527 ,(1982) , 10.1016/0090-4295(82)90127-3
J W Lomasney, S Cotecchia, W Lorenz, W Y Leung, D A Schwinn, T L Yang-Feng, M Brownstein, R J Lefkowitz, M G Caron, Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5. Journal of Biological Chemistry. ,vol. 266, pp. 6365- 6369 ,(1991) , 10.1016/S0021-9258(18)38126-2
U. Jonas, C. C. Schulman, M. J. Speakman, J. Cortvriend, S. Vaage, T. M. T. W. Lock, Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. European Urology. ,vol. 29, pp. 145- 154 ,(1996)
Robert M. Graham, Dianne M. Perez, Michael T. Piascik, Solution-phase library screening for the identification of rare clones: isolation of an alpha 1D-adrenergic receptor cDNA. Molecular Pharmacology. ,vol. 40, pp. 876- 883 ,(1991)